EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

IL-33 regulates Müller cell-mediated retinal inflammation and neurodegeneration in diabetic retinopathy

Josy Augustine iD, Sofia Pavlou iD, Kevin Harkin iD, Alan W Stitt iD, Heping Xu iD, Mei Chen iD

Disease Models & Mechanisms · 01.09.2023 · 16 (9)

DOI: 10.1242/dmm.050174 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Disease Models & Mechanisms, online erschienen am 06.09.2023. Verfasst von Josy Augustine und 5 weiteren Autor:innen. Beteiligte Einrichtung: Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast BT9 …. Hauptthemen laut MEDLINE: Diabetes Mellitus, Experimental, Diabetic Retinopathy, Interleukin-33. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Education, Northern Ireland, Fight for Sight UK, Sight Research UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic retinopathy (DR) is characterised by dysfunction of the retinal neurovascular unit, leading to visual impairment and blindness. Müller cells are key components of the retinal neurovascular unit and diabetes has a detrimental impact on these glial cells, triggering progressive neurovascular pathology of DR. Amongst many factors expressed by Müller cells, interleukin-33 (IL-33) has an established immunomodulatory role, and we investigated the role of endogenous IL-33 in DR. The expression of IL-33 in Müller cells increased during diabetes. Wild-type and Il33−/− mice developed equivalent levels of hyperglycaemia and weight loss following streptozotocin-induced diabetes. Electroretinogram a- and b-wave amplitudes, neuroretina thickness, and the numbers of cone photoreceptors and ganglion cells were significantly reduced in Il33−/− diabetic mice compared with those in wild-type counterparts. The Il33−/− diabetic retina also exhibited microglial activation, sustained gliosis, and upregulation of pro-inflammatory cytokines and neurotrophins. Primary Müller cells from Il33−/− mice expressed significantly lower levels of neurotransmitter-related genes (Glul and Slc1a3) and neurotrophin genes (Cntf, Lif, Igf1 and Ngf) under high-glucose conditions. Our results suggest that deletion of IL-33 promotes inflammation and neurodegeneration in DR, and that this cytokine is critical for regulation of glutamate metabolism, neurotransmitter recycling and neurotrophin secretion by Müller cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, ExperimentalDiabetic RetinopathyInterleukin-33AnimalsMiceCytokinesEpendymoglial CellsInflammationRetina

Stichwörter der Autor:innen

CytokinesDiabetesInterleukin-33NeurotrophinsNeurovascular unitRetina

Substanzen

CytokinesInterleukin-33Il33 protein, mouse

Autor:innen und Institutionen

  • Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast BT9 7BL, Northern Ireland, UK.

ORCID-Profile: Josy Augustine, Sofia Pavlou, Kevin Harkin, Alan W Stitt, Heping Xu, Mei Chen

Förderung

  • Department of Education, Northern Ireland
  • Fight for Sight UK
  • Sight Research UK
  • Queen's University Belfast

Zitieren

APA

Augustine, J., Pavlou, S., Harkin, K., Stitt, A. W., Xu, H., & Chen, M. (2023). IL-33 regulates Müller cell-mediated retinal inflammation and neurodegeneration in diabetic retinopathy. Disease Models & Mechanisms, 16(9). https://doi.org/10.1242/dmm.050174

Vancouver

Augustine J, Pavlou S, Harkin K, Stitt AW, Xu H, Chen M. IL-33 regulates Müller cell-mediated retinal inflammation and neurodegeneration in diabetic retinopathy. Disease Models & Mechanisms. 2023;16(9). doi:10.1242/dmm.050174

BibTeX
@article{Augustine2023,
  author = {Augustine, Josy and Pavlou, Sofia and Harkin, Kevin and Stitt, Alan W and Xu, Heping and Chen, Mei},
  title = {IL-33 regulates Müller cell-mediated retinal inflammation and neurodegeneration in diabetic retinopathy},
  journal = {Disease Models & Mechanisms},
  year = {2023},
  volume = {16},
  number = {9},
  doi = {10.1242/dmm.050174}
}
Kostenlos starten →